The U.S. Department of Health and Human Services said it would wind down mRNA vaccine development activities under its biomedical research unit.

The Department of Health and Human Services is terminating around $500 million in BARDA contracts associated with mRNA ...

Infectious disease experts say the mRNA technology used in vaccines is safe, and they credit its development during the first ...

Novavax raised its full-year adjusted revenue forecast on Wednesday, banking on higher sales tied to its vaccine supply ...